Health Care·Health Care Equipment·$92.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.23 | N/A | -26.05% |
management commentary, guidance changes, and full analysis available with Pro.
| -26.05% |
Tone: Cautiously Optimistic
Overall, management acknowledged the difficulties faced during the quarter but maintained a positive outlook for future growth. They emphasized their commitment to innovation and market expansion.
Management highlighted ongoing challenges but expressed confidence in long-term growth.
They noted improvements in certain product lines despite the current environment.
Boston Scientific's earnings report showed a significant miss on EPS, which may raise concerns among investors about profitability. However, the stock reacted positively, increasing by 2.21%, likely due to management's optimistic tone about long-term growth and product improvements. Investors may be encouraged by the company's focus on innovation despite current challenges.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ON SEMICONDUCTOR COR
Feb 1, 2021